Neotherix CEO Dr Mike Raxworthy will be speaking at the World Conference on Regenerative Medicine 2013, to be held in Leipzig, Germany on 23-25 October. The interdisciplinary conference, which is expected to be attended by around 1,000 delegates, covers a broad range of regenerative medicine topics ("from biomaterials to biomarkers and regulation to stem cell technologies").
Mike's presentation will be given during the Soft Tissue Regeneration session on Day 2 of the conference, 24 October, and will focus on the in vivo performance of our EktoTherix™ regenerative scaffold technology. The work showed that highly proliferative and viable cells started to populate and replace the polymer scaffold within the first four days, and that bioresorption of the polymer and the resolution of any local (macrophage) tissue reactions were complete by day 42. Compression of the scaffold into the wound bed improved scaffold integration and positively influenced the depth and area of granulation tissue formed. The study provided evidence that the use of EktoTherix may result in improved wound cosmesis and also provided proof of concept for the use of EktoTherix in excisional wound repair.
For more information, please see the World Conference on Regenerative Medicine web page .